Opportunities and challenges for user-generated licensing models in gene-editing

Timo Minssen; Esther  Van Zimmeren; Jakob Wested

Opportunities and challenges for user-generated licensing models in gene-editing

Timo Minssen, Esther Van Zimmeren, Jakob Wested

Abstract

A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.

Originalsprog	Engelsk
Publikationsdato	jul. 2018
Udgiver	Harvard Law School's Bill of Health blog
Status	Udgivet - jul. 2018

Adgang til dokumentet

http://blogs.harvard.edu/billofhealth/2018/07/14/could-user-generated-licensing-models-help-us-to-clear-a-path-through-the-crispr-patent-jungle/

Citationsformater

@misc{df18c1edab8d4ebfa0125001b33d9b7e,

title = "Opportunities and challenges for user-generated licensing models in gene-editing",

abstract = "A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.",

author = "Timo Minssen and {Van Zimmeren}, Esther and Jakob Wested",

year = "2018",

month = jul,

language = "English",

publisher = "Harvard Law School's Bill of Health blog",

type = "Other",

}

TY - ICOMM

T1 - Opportunities and challenges for user-generated licensing models in gene-editing

AU - Minssen, Timo

AU - Van Zimmeren, Esther

AU - Wested, Jakob

PY - 2018/7

Y1 - 2018/7

N2 - A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.

AB - A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.

M3 - Net publication - Internet publication

PB - Harvard Law School's Bill of Health blog

ER -

Opportunities and challenges for user-generated licensing models in gene-editing

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater